Sign Up Today and Learn More About Sensorium Therapeutics Stock
Invest in or calculate the value of your shares in Sensorium Therapeutics or other pre-IPO companies through EquityZen's platform.
Sensorium Therapeutics Stock (SEOT)
Sensorium Therapeutics is a drug discovery platform that develops novel FDA-approved psychoactive medicines.
About Sensorium Therapeutics Stock
Founded
2021
Headquarters
Boston, MA, US
Industries
Software, Data and Analytics, Artificial Intelligence
Sensorium Therapeutics Press Mentions
Stay in the know about the latest news on Sensorium Therapeutics
Sensorium Therapeutics describes new SERT and PDE4 inhibitors
bioworld • Jun 08, 2024
Sensorium Therapeutics Appoints Sam Rasty as Chief Business Officer
prnewswire • May 23, 2024
Sensorium Therapeutics Appoints Sam Rasty as Chief Business Officer
biospace • Apr 17, 2024
Delivery of therapeutic alkaloid compounds
patents • Apr 14, 2024
Solid forms of mesembrine and therapeutic uses thereof
patents • Apr 14, 2024
Sensorium Therapeutics Management
Leadership team at Sensorium Therapeutics
Co-Founder, Chief Executive Officer & Board Member
Richard Simon
Co-Founder & Chief of Staff
Alex Simon
Join now and verify your accreditation status to gain access to:
- Sensorium Therapeutics current valuation
- Sensorium Therapeutics stock price
- Available deals in Sensorium Therapeutics and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Sensorium Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Sensorium Therapeutics through EquityZen funds. These investments are made available by existing Sensorium Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Sensorium Therapeutics stock?
Shareholders can sell their Sensorium Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 320K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 42K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
